CLNN
$7.85
Clene
($1.33)
(14.49%)
CLNN
Earnings Whisper ®
N/A
2nd Quarter June 2021
Consensus:  ($0.10)
Revenue:  $0.06 Mil
Tuesday
Aug 10
7:00 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when CLNN reports earnings?
Beat
Meet
Miss

Where is CLNN's stock price going from here?
Up
Flat
Down
Stock chart of CLNN
Analysts
Summary of analysts' recommendations for CLNN
Score
Grade
Pivots
Resistance
$10.68
$9.93
$8.89

$8.14

Support
$7.10
$6.35
$5.31
Tweet
Growth
Description
Clene Inc. is a clinical-stage biopharmaceutical company. It is focused on the development of unique therapeutics for neurodegenerative diseases. Clene Nanomedicine Inc., formerly known as Tottenham Acquisition I Limited, is based in SALT LAKE CITY.